JPRN-UMIN000029085
招募中
未知
Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndrome - Clinical trial of 3,4-diaminopyridine(3,4-DAP) for the Lambert-Eaton myasthenic syndrome
Gunma university graduate school of medicine0 个研究点目标入组 1 人2017年10月1日
概览
- 阶段
- 未知
- 干预措施
- 未指定
- 疾病 / 适应症
- ambert-Eaton myasthenic syndrome(LEMS)
- 发起方
- Gunma university graduate school of medicine
- 入组人数
- 1
- 状态
- 招募中
- 最后更新
- 2年前
概览
简要总结
The study was terminated because the target number of participants was not reached and the study was not evaluable.
研究者
入排标准
入选标准
- 未提供
排除标准
- •1\. serum anti\-acetylcholie receptor antibody positive 2\. serum anti\-MuSK antibody positive 3\. pregnancy 4\. epilepsy 5\. iver dysfunction 6\. renal dysfunction 7\. abnormal ECG findings 8\. the patient who judged inappropriate from the doctor
结局指标
主要结局
未指定
相似试验
已完成
不适用
DOMINIC - Non-interventional Study about Dose modifications of Docetaxel in the therapy of metastatic castration resistant Prostate CancerC61Malignant neoplasm of prostateDRKS00007955AxioNovo Gmbh168
已完成
4 期
Efficacy of coronary artery calcification on DenosumabPatients with osteoporosis with coronary artery calcificationosteoporosis, coronary artery calcificationJPRN-jRCT1031190025Kubota Naoki1
已完成
不适用
Study for necessity of insulin treatment in two enteral feeding formulas which are different in carbohydrates and fatty acids concentrations in tube-fed subjects with type 2 diabetes mellitustype 2 diabetes mellitus, Cerebral vascular diseaseJPRN-UMIN000001784Saiseikai Central Hospital40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40